We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+15.08%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
-$122M
Cap. Flow
-$406M
Cap. Flow %
-21.88%
Top 10 Hldgs %
74.46%
Holding
121
New
44
Increased
20
Reduced
8
Closed
32

Top Buys

1
TECD
Tech Data Corp
TECD
+$29.6M
2
TIF
Tiffany & Co.
TIF
+$26.6M
3
LPT
Liberty Property Trust
LPT
+$17.2M
4
AGN
Allergan plc
AGN
+$16.2M
5
MDCO
Medicines Co
MDCO
+$13.3M

Top Sells

1
CELG
Celgene Corp
CELG
+$44.7M
2
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$13.8M
3
CBM
Cambrex Corporation
CBM
+$7.14M
4
WBC
WABCO HOLDINGS INC.
WBC
+$7.02M
5
GWR
Genesee & Wyoming Inc.
GWR
+$6.91M

Sector Composition

1 Healthcare 5.9%
2 Technology 2.24%
3 Consumer Discretionary 1.32%
4 Industrials 1.16%
5 Financials 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBTYK icon
26
Liberty Global Class C
LBTYK
$3.41B
$3.8M 0.21%
174,462
+90,262
+107% +$2.03M
W icon
27
PUT
Wayfair
W
$11.7B
$3.8M 0.2%
42,000
+20,000
+91% +$1.87M
CBPX
28
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$3.64M 0.2%
+100,000
New +$3.29M
BOLD
29
DELISTED
Audentes Therapeutics, Inc
BOLD
$3.59M 0.19%
+60,000
New +$2.25M
BMRN icon
30
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
$3.47M 0.19%
41,000
+14,000
+52% +$1.06M
BREW
31
DELISTED
Craft Brew Alliance, Inc.
BREW
$3.46M 0.19%
+210,000
New +$2.62M
HPQ icon
32
HP
HPQ
$22.8B
$3.29M 0.18%
+160,000
New +$3.03M
WMGI
33
PUT
DELISTED
Wright Medical Group Inc
WMGI
$3.27M 0.18%
107,200
+57,200
+114% +$1.5M
TDOC icon
34
Teladoc Health
TDOC
$1.69B
$3.25M 0.18%
38,800
+7,800
+25% +$594K
PACB icon
35
Pacific Biosciences
PACB
$450M
$3.08M 0.17%
600,000
-400,000
-40% -$2.03M
SIOX
36
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3.07M 0.17%
598,700
+283,000
+90% +$1.57M
DRRX
37
CALL
DELISTED
DURECT Corp
DRRX
$2.6M 0.14%
+68,480
New +$1.41M
RARX
38
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.35M 0.13%
+50,000
New +$2.21M
UA icon
39
Under Armour Class C
UA
$3.07B
$2.29M 0.12%
119,607
-60,493
-34% -$1.06M
THOR
40
CALL
DELISTED
Synthorx, Inc. Common Stock
THOR
$2.29M 0.12%
+32,800
New +$937K
X
41
PUT
DELISTED
US Steel
X
$2.23M 0.12%
+195,000
New +$2.42M
APLS
42
PUT
DELISTED
Apellis Pharmaceuticals
APLS
$2.14M 0.12%
+70,000
New +$1.94M
BKNG icon
43
PUT
Booking.com
BKNG
$141B
$2.05M 0.11%
25,000
– –
AVX
44
DELISTED
AVX Corporation
AVX
$2.05M 0.11%
+100,000
New +$1.72M
APLS
45
DELISTED
Apellis Pharmaceuticals
APLS
$2.04M 0.11%
+66,800
New +$1.85M
TVTX icon
46
PUT
Travere Therapeutics
TVTX
$5.31B
$2.01M 0.11%
141,500
-415,600
-75% -$5.31M
ICPT
47
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.98M 0.11%
+16,000
New +$1.43M
ON icon
48
ON Semiconductor
ON
$34.1B
$1.95M 0.1%
79,800
+34,900
+78% +$737K
BMRN icon
49
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.95M 0.1%
23,000
+200
+0.9% +$15.1K
BMRN icon
50
CALL
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.86M 0.1%
22,000
+16,000
+267% +$1.21M
1
2
3 4 5

Similar funds

PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return

DLD Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, DLD Asset Management held 121 positions worth $1.85B, down 6.2% from $1.98B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DLD Asset Management withdrew a net $406M in Q4 2019, closing 32 positions and reducing 8 holdings. Its most notable exit was Celgene Corp, an estimated $44.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.9% of assets, up from 5.2% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, DLD Asset Management opened a new position in Tech Data Corp worth $33M.

  • DLD Asset Management's largest Q4 2019 buy was Tech Data Corp: 230,000 shares worth $33M.
  • DLD Asset Management added most to Allergan plc in Q4 2019, an estimated $16.2M increase.
  • DLD Asset Management's biggest Q4 2019 reduction was WABCO HOLDINGS INC., cutting an estimated $7.02M.
  • DLD Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $44.7M.
  • DLD Asset Management's ten largest holdings make up 74% of its $1.85B portfolio in Q4 2019.
  • DLD Asset Management opened 44 new positions and closed 32 in Q4 2019.
  • DLD Asset Management's portfolio value fell 6.2% quarter-over-quarter to $1.85B.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.